Toxic releases "190,000 times superior" to the standard at the Sanofi plant in Mourenx

According to franceinfo and Mediapart, Sanofi plant in the Lacq basin in Mourenx (Pyrénées-Atlantiques), which produces the Dépakine, pollutes well beyond the authorized standards.

According to Mediapart, the incriminated toxic discharges reach "astronomical" levels: »up to 190,000 above the permissible ceiling for bromopropane, a substance that can impair fertility and the fetus. "The product, which is completely odorless, is clbadified as a carcinogenic mutagen with effects that may affect fertility. "This situation should never happen. This is a serious case, "says Solène Demonet, coordinator of the industrial risk and impact network of France Nature Environnement (FNE), one of the largest national environmental NGOs, cited by the information website.

Developmental Disorders at the fetus

And according to franceinfo, the site would also reject sodium valporate, the base of Dépakine, the anti-epilepsy drug used in cases of developmental disorders in the fetus. It has recently been banned for women of childbearing or pregnant age. The Health Insurance and the Agence du médicament (ANSM) estimates that this drug could be responsible for malformations in 2,150 to 4,100 children, and neurodevelopmental disorders in 16,600 to 30,400 others.

The measurements of pollutants rejected were made in April 2018. Mediapart quotes in support of its report a four-page report of the Regional Directorate for the Environment, Planning and Housing (Dreal), under Aegis of the Prefecture of Pyrénées-Atlantiques, dated April 14, 2018. According to Franceinfo, France Nature Environment Association decided to file a complaint Monday, July 9 against the plant in question.